BIRMINGHAM, Ala. ( WBRC) - Alabama Attorney General Steve Marshall has announced that the state settled a lawsuit with a ...
Glucocorticoid injections into the infrapatellar fat pad do not reduce knee pain or effusion synovitis volume in patients ...
IV iron dextran is most cost-effective, yielding 19.26 QALYs compared with 19.10 QALYs for oral ferrous sulfate.
A new study demonstrates the effectiveness of a widely-used eye injection to manage the previously untreatable rare condition ...
The FDA has cleared a mobile application that will connect with a next-generation multiple daily injection automated insulin ...
Dr. Ian Flinn explains in an interview with CURE how Lunsumio VELO (mosunetuzumab) works and its impact on patients with ...
News-Medical.Net on MSN
New oral drug safely lowers triglycerides and other blood lipids in Phase 1 trial
In a Phase 1 clinical study, researchers led by EPFL and their partners report that a new liver- and gut-targeted oral drug ...
“The FDA’s Breakthrough Therapy Designation for pemvidutide in MASH reinforces the promise of its clinical profile and potential to address significant unmet needs in this serious, progressive liver ...
Combination therapy of botensilimab (BOT) plus balstilimab (BAL) was approved Monday as an updated national treatment protocol for patients with certain ovarian cancers and soft tissue sarcomas (STS) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback